Coronary heart disease benefits from blood pressure and lipid-lowering.

Category Primary study
JournalInternational journal of cardiology
Year 2009
BACKGROUND: We have reported the benefits of atorvastatin and of an amlodipine-based regimen on coronary heart disease (CHD) events in hypertensive patients in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). We report further analyses on the combined benefits of these interventions. METHODS: 19,342 hypertensive patients were randomised to either an amlodipine or an atenolol-based regimen in the ASCOT Blood Pressure-Lowering Arm (BPLA). 10,305 subjects with total cholesterol
Epistemonikos ID: b41e1eb9e1692bbd7134a92ab251b7965fd36542
First added on: May 09, 2022